Corporate Members 2017-12-11T10:19:43+00:00

Corporate Members

Corporate Membership

COA maintains a Corporate Member Program for qualified industry companies including biotechnology, pharmaceutical, genomic, drug delivery and distribution, and other entities. This is consistent with COA’s mission of uniting the cancer community in order to enhance the quality of cancer care. The purpose of the Corporate Member Program is to:

  • Foster enhanced communications between community oncology and corporate members to improve the cancer care delivery system
  • Provide a forum for addressing common issues (not specific brands/products or product-specific issues) that impact patient care delivery

COA maintains a strict policy of independence from commercial influences, such as those related to specific companies, products, or services. The COA Board of Directors enforces this policy. Fundamentally, a mission of fostering and protecting the quality, affordability, and accessibility of cancer care for all Americans governs every COA policy and endeavor. Funds are used for education, projects, advocacy, staffing, and to maintain an office in Washington, DC.

Not A Corporate Member Yet? CLICK HERE to sign up!

Abbvie
Adaptive Biotechnologies
Abbvie
Abbvie
Apobiologix
Astellas
Astrazeneca
Bristol-Myers Squibb
Boehringer Ingelheim
Cardinal
Celgene
Coherus
Daiichi-Sankyo
Eisai
Emdserono
Emdserono
Flatiron
Foundation Medicine
Genentech
Genomic Health
Helsinn
Heron
Hospira
Incyte
ION Solutions
IPSEN
Janssen
Lilly
Mckesson
Medivation
Merck
Myriad
Nanostring
Novartis
Oncology Supply
Pfizer
Phrma
Pharmacyclics
Sandoz
Sonfi Aventis
Seattle Genetics
Spectrum
Taiho
Tesaro
Takeda
Teva
Tolmar
Walgreens

COA INITIATIVES